Cogent Biosciences, Inc. Balance Sheet

Balance Sheet Dec2017 Dec2018 Dec2019 Dec2020
Assets
Current Assets
Cash & Equivalents 36.89M75.02M37.42M242.19M
Short-term Investments 12.69M22.92M
Cash & Current Investments 49.58M97.95M37.42M242.19M
Receivables - Net 0.83M1.67M2.00M
Receivables 0.83M1.67M2.00M
Prepaid Assets 0.51M0.74M1.17M2.72M
Current Assets 42.38M81.00M40.59M244.91M
Non-Current Assets
Property, Plant & Equipment (Net) 4.11M3.25M1.86M0.13M
Other Non-Current Assets 1.37M1.25M1.25M1.25M
Non-Current Assets 6.74M4.92M8.83M6.00M
Assets 49.12M85.93M49.42M250.92M
Liabilities
Current Liabilities
Accounts Payables 1.35M1.52M3.18M0.73M
Payables 1.35M1.52M3.18M0.73M
Accumulated Expenses 2.95M5.48M7.13M4.78M
Other Accumulated Expenses 0.18M0.31M
Current Leases 1.62M2.05M
Current Deferred Revenue 6.89M17.95M1.31M
Total Current Liabilities 11.19M24.95M13.25M13.09M
Non-Current Liabilities
Non-Current Deffered Revenue 8.71M0.75M
Preferred Stock Liabilities 77.15M110.88M
Operating Leases 4.41M3.15M
Other Non-Current Liabilities 5.53M
Total Non-Current Liabilities 10.72M
Total Liabilities 20.81M25.69M17.66M16.25M
Shareholder's Equity
Common Equity -48.85M60.23M31.76M234.67M
Shareholder's Equity -48.85M60.23M31.76M234.67M
Liabilities and Shareholders Equity 49.12M85.93M49.42M250.92M
Retained Earnings -51.34M-92.06M-123.89M-198.70M
Preferred Shares 110.88M
Treasury Shares 0.09M